Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 1, 2014, Pages 128-136

  Saida, Tomomi ^a   Fukushima, Wakaba ^b   Ohfuji, Satoko ^b   Kondo, Kyoko ^b   Matsunaga, Ichiro ^b   Hirota, Yoshio ^b  

^a Department of Urology   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Additive interaction; Body fat percentage; Body mass index; Fatty liver; Synergy index

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; BODY MODIFICATION; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; WEIGHT GAIN;

ADDITIVE INTERACTION; BODY FAT PERCENTAGE; BODY MASS INDEX; FATTY LIVER; SYNERGY INDEX;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY FAT DISTRIBUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; RISK; SEX FACTORS; WEIGHT GAIN;

EID: 84897595187     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12377     Document Type: Article

References (36)

1. Committee for the Diagnostic Criteria of Metabolic Syndrome. The definition and diagnostic criteria of metabolic syndrome (in Japanese). J. Jpn. Soc. Int. Med. 2005; 94: 794-809.
2. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1741-1749.
3. Hamaguchi M, Kojima T, Takeda N etal. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J. Gastroenterol. 2007; 13: 1579-1584.
4. Yamada T, Fukatsu M, Suzuki S etal. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J. Gastroenterol. Hepatol. 2010; 25: 352-356.
5. Kim CH, Park JY, Lee KU etal. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet. Med. 2008; 25: 468-481.
6. Hamaguchi M, Kojima T, Takeda N etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728.
7. Tsuneto A, Hida A, Sera N etal. Fatty liver incidence and predictive variables. Hypertens. Res. 2010; 33: 638-643.
8. Dai H, Chu L, Song S etal. Prevalence of and risk factors for fatty liver disease in a professional population of Wuhan, China. Public Health 2009; 123: 545-548.
9. Gunji T, Matsuhashi N, Sato H etal. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am. J. Gastroenterol. 2009; 104: 2189-2195.
10. Chang Y, Ryu S, Sung E etal. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 2009; 58: 1419-1425.
11. Marchesini G, Brizi M, Bianchi G etal. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
12. Weston SR, Leyden W, Murphy R etal. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005; 41: 372-379.
13. Omagari K, Kadokawa Y, Masuda J etal. Fatty liver in non-alcoholic, non-overweight Japanese adults: incidence and clinical characteristics. J. Gastroenterol. Hepatol. 2002; 17: 1098-1105.
14. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 2003; 38: 9954-9961.
15. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension. Guidelines for the management of hypertension for general practitioners. Hypertens. Res. 2001; 24: 613-634.
16. Rothman KL. Epidemiology: An introduction. New York: Oxford University Press, 2002.
17. Fukushima W, Yamamoto T, Takahashi S etal. The effect of alcohol intake and the use of oral corticosteroids on the risk of idiopathic osteonecrosis of the femoral head. Bone Joint J. 2013; 95-B: 320-325.
18. Chen QK, Chen HY, Huang KH etal. Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J. Gastroenterol. 2004; 10: 899-902.
19. Ikeda K, Saitoh S, Suzuki Y etal. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J. Hepatol. 1998; 128: 930-938.
20. McMahon BJ, Alberts SR, Wainwright RB etal. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch. Intern. Med. 1990; 150: 1051-1054.
21. van der Poorten D, Milner KL, Hui J etal. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48: 449-457.
22. Park SH, Kim BI, Kim SH etal. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J. Am. Coll. Nutr. 2007; 26: 321-326.
23. Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann. Acad. Med. Singapore 2009; 38: 57-65.
24. Eguchi Y, Hyogo H, Ono M etal. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J. Gastroenterol. 2012; 47: 586-595.
25. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y. Regular physical activity and coronary risk factors in Japanese men. Circulation 1998; 97: 661-665.
26. Dixon J, Bhathal P, Hughes N, O'Brien P. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-1654.
27. Tadokoro N, Shinomiya M, Yoshinaga M etal. Visceral fat accumulation in Japanese high school students and related atherosclerotic risk factors. J. Atheroscler. Thromb. 2010; 17: 546-557.
28. Iwasaki M, Yamamoto S, Otani T etal. Generalizability of relative risk estimates from a well-defined population to a general population. Eur. J. Epidemiol. 2006; 21: 253-262.
29. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956.
30. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J. Hepatol. 2009; 51: 918-924.
31. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J. Gastroenterol. 2010; 21: 2579-2588.
32. Steinmaurer HJ, Jirak P, Walchshofer J, Clodi PH. Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases-comparison of sonography and liver histology. Ultraschall Med. 1984; 5: 98-103.
33. Needleman L, Kurtz AB, Rifkin MD, Cooper H, Pasto M, Goldberg B. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am. J. Roentgenol. 1986; 146: 1011-1015.
34. Joseph AE, Saverymuttu SH, al-Sam S, Cook M, Maxwell J. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin. Radiol. 1991; 43: 26-31.
35. Mendler MH, Bouillet P, Le Sidaner A etal. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J. Hepatol. 1998; 28: 785-794.
36. Graif M, Yanuka M, Baraz M etal. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest. Radiol. 2000; 35: 319-324.